Akouos, a Boston, MA-based new biotechnology startup focused on restoring and preserving hearing has raised $7.5 million in seed funding led by 5AM Ventures and New Enterprise Associates (NEA), with participation from Partners Innovation Fund. Spun out of Harvard Innovation Labs in 2017, Akouos is developing novel therapies and delivery systems to prevent hearing loss and restore hearing in genetically defined patient populations.In addition to the seed round of funding, Akouos has entered into
Read More
Biotech startups
Pfizer Spin Off Lands $103M to Develop New Drugs for Undeserved Patient Populations
SpringWorks Therapeutics, a new Pfizer spin-off launched as a way to advance investigational drug therapies that may hold significant promise for underserved patients has raised $103 million in funding in Series A funding. The Series A round was led by Bain Capital Life Sciences, Bain Capital Double Impact, OrbiMed, Pfizer and LifeArc (formerly known as MRC Technology). SpringWorks Therapeutics’ collaborative business model is designed to deliver both social and financial returns via
Read More
Nightingale Health Obtains CE Mark for Blood Analysis Platform
Finnish biomedical startup Nightingale Health has obtained CE marking for its blood biomarker analysis platform. The CE mark enables the clinical use of the analysis service and the analysed measures of creatinine and glucose in the EU region.Nightingale Health's blood biomarker analysis platform is based on NMR (Nuclear Magnetic Resonance) spectroscopy. It captures over 228 metabolic biomarkers from a single blood sample, transforming the possibility to understand molecular mechanisms and
Read More
Biotech Startup Lantern Pharma Raises $3.7M to Accelerate Cancer Drug Approval Process
Clinical-stage biotech company Lantern Pharma Inc. has raised $3.7 million in Series A funding led by BIOS Partners, GPG Ventures and other private investors. Using big data and artificial intelligence, Lantern Pharma focused exclusively on accelerating the cancer drug approval process.The startup plans to utilize the funding to continue development of its two lead drug candidates and further the advancement of its big data and Artificial Intelligence (AI) platform. Lantern’s strategy focuses on
Read More
ID Genomics Awarded $3.5M NIH Grant To Develop Genetic Barcoding Database for Antibiotic Treatment
Seattle biotech startup ID Genomics has been awarded a $3 million National Institutes of Health (NIH) grant to develop a genetic "barcoding" test and global database to help doctors prescribe the correct antibiotic before patients leave the clinic.The rapid (30-minute) genetic “barcoding” test uniquely identifies bacterial strains that are stored in a proprietary database and linked to particular antibiotic resistance profiles. This database can then be used by doctors to quickly identify
Read More
